Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-15T22:15:05.453Z Has data issue: false hasContentIssue false

Impact of rapid Cepheid Xpert Xpress severe acute respiratory coronavirus virus 2 (SARS-CoV-2) reverse-transcription polymerase chain reaction (RT-PCR) testing in Detroit Medical Center hospitals during the coronavirus disease 2019 (COVID-19) pandemic

Published online by Cambridge University Press:  13 September 2022

Monica P. Meyer
Affiliation:
Wayne State University School of Medicine, Detroit, Michigan
Jennifer LeRose
Affiliation:
Michigan State University, College of Osteopathic Medicine, East Lansing, Michigan
Catherine Maples
Affiliation:
Wayne State University School of Medicine, Detroit, Michigan
Teena Chopra*
Affiliation:
Wayne State University School of Medicine, Detroit, MichiganDivision of Infectious Disease, Department of Internal Medicine, Detroit Medical Center, Detroit, Michigan
*
Author for correspondence: Teena Chopra, MD, MPH, Detroit Medical Center, 3990 John R Street, Detroit, MI, 48201. E-mail: tchopra@med.wayne.edu

Abstract

In March 2020, the coronavirus disease 2019 (COVID-19) pandemic raged, and samples from the Detroit Medical Center (DMC) were sent offsite for testing. From April 3, 2020, DMC laboratories ran rapid Cepheid Xpert Xpress severe acute respiratory coronavirus virus 2 (SARS-CoV-2) reverse-transcription polymerase chain reaction (RT-PCR) tests within hospital labs. We detected differences in length of stay (LOS) and antibiotic duration between positive results from offsite and in-house tests.

Information

Type
Concise Communication
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Table 1.Descriptive Characteristics of Patient Encounters by Test Type

Figure 1

Fig. 1.Length of hospital stay among patients whose SAR-CoV-2 test was performed using Cepheid rapid PCR or by external laboratories (March 12, 2020, to April 30, 2020).